Amphastar Pharmaceuticals...

NASDAQ: AMPH · Real-Time Price · USD
29.87
-0.34 (-1.13%)
At close: Aug 15, 2025, 3:59 PM
29.83
-0.13%
After-hours: Aug 15, 2025, 07:19 PM EDT

Amphastar Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
31.03M 25.29M 37.96M 40.43M 37.95M 43.18M 36.17M 49.22M 26.12M 26.03M 33.91M 15.87M 17.35M 24.25M 19.76M 30.96M 8.62M 3.96M
Depreciation & Amortization
13.02M 15.21M 14.66M -4.11M 14.14M 13.96M 13.79M 13.57M 7.02M 7.4M 7.43M 7.49M 7.02M 6.79M 6.55M 6.51M 6.87M 6.83M
Stock-Based Compensation
6.38M 8.39M 5.63M 5.6M 5.78M 7.36M 4.62M 4.64M 4.87M 6.11M 4.3M 4.3M 4.24M 5.02M 3.85M 3.92M 6.08M 4.83M
Other Working Capital
-21.11M 4.87M 10.86M -16.61M -4.74M 2.85M -32.26M 13.22M 5.51M 5.82M -2.74M -8.12M -18.16M 4.65M 1.74M 614K 1.04M 1.55M
Other Non-Cash Items
3.69M 2.91M -20.65M 25.37M 2.6M -1.94M 8.61M 5.24M -3M 982K -822K 2.95M -11.36M -2.31M 218K -13.56M 308K 6K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -12.58M -2.6M 11.49M n/a -15.75M n/a n/a n/a -961K 5.17M n/a n/a
Change in Working Capital
-18.52M -16.71M -8.59M -7.33M 8.63M -7.26M -26.75M -5.74M 8.42M -139K -13.85M -10.23M -25.09M 17M 11.02M -30.43M 10.28M 7.2M
Operating Cash Flow
35.59M 35.08M 29.02M 59.96M 69.11M 55.29M 23.86M 64.33M 54.92M 40.38M 15.23M 20.38M 2.81M 50.77M 40.44M 2.57M 32.16M 22.82M
Capital Expenditures
-10.56M -10.7M -12.41M -13.79M -6.04M -8.79M -9.44M -10.19M -9.05M -9.48M -6.31M -5.62M -5.96M -6.14M -6.88M -7.22M -5.74M -7.62M
Cash Acquisitions
n/a n/a n/a 129M -129M n/a 506.41M -5.58M -500.83M n/a n/a n/a 421K n/a n/a n/a n/a n/a
Purchase of Investments
-8.51M -7.11M -29.29M -25.96M 960K -22.51M -91.75M -33.03M -9.2M -10.57M -5.19M -18.56M -6.69M -5.32M -4.92M -5.22M -2.74M -4.5M
Sales Maturities Of Investments
23.03M 28.29M 7.48M 5.26M 65.78M 47.5M -179K 13.65M 11.09M 14.06M 12.5M 9.07M 3.86M 2.54M 1.35M 8.95M 4.53M 3.94M
Other Investing Acitivies
-4.58M n/a -1.47M -129.1M -1.6M -960K -508.08M 4M -586K -346K -1.23M -145K 192K -189K -1.51M -279K -305K -520K
Investing Cash Flow
-625K 10.48M -35.68M -34.59M -69.9M 15.24M -103.05M -31.15M -508.58M -6.33M -229K -15.26M -8.18M -9.11M -11.95M -3.77M -4.25M -8.7M
Debt Repayment
3.84M 1.6M 4.75M 9.47M -8.03M 3.98M -50.15M 144.93M 432.54M -968K -128K -522K -593K -538K -613K 40.75M -6.04M -2M
Common Stock Repurchased
11M -11M -42M -34.96M -8.5M -17.31M n/a -50M -128K -8.02M -18.07M -14.49M -6.12M -1.23M -13.44M -6.09M -5.56M -3.78M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.68M -5.11M 3.41M 2.67M 1K -252K -491K -8.31M -14.15M -4.57M 2.04M 1.08M 5.72M 6.42M 5.35M -51.15M 5.55M -854K
Financial Cash Flow
-30.2M -14.5M -33.84M -22.82M -10.72M -13.58M -47.08M 86.61M 428.11M -13.55M -16.16M -13.93M -994K 4.65M -8.7M -16.49M -5.19M -6.64M
Net Cash Flow
4.91M 31.17M -40.51M 2.5M -11.53M 56.85M -126.51M 119.76M -25.57M 20.52M -1.15M -8.91M -6.47M 46.27M 19.74M -17.75M 22.75M 7.33M
Free Cash Flow
25.03M 24.38M 16.61M 46.17M 63.06M 46.5M 14.42M 54.14M 45.87M 30.91M 8.92M 14.75M -3.15M 44.63M 33.56M -4.65M 26.42M 15.21M